AVALO THERAPEUTICS, INC. Number of Operating Segments
AVALO THERAPEUTICS, INC. (AVTX) reported Number of Operating Segments of 1 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfOperatingSegments · last filed 2026-08-06
- AVALO THERAPEUTICS, INC. number of operating segments for the quarter ending 2016-03-31 was 1.00 item.
item
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month |
|---|---|---|---|
| 2016-09-30 | 1.00 item 10-Q · filed 2016-11-08 | ||
| 2016-06-30 | 1.00 item 10-Q · filed 2016-08-15 | ||
| 2016-03-31 | 1.00 item 10-Q · filed 2016-05-16 |
segment
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 segment 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | 1.00 segment 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | 1.00 segment 10-K · filed 2026-03-23 | |||
| 2025-09-30 | 1.00 segment 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | 1.00 segment 10-Q · filed 2025-08-07 | |||
| 2025-03-31 | 1.00 segment 10-Q · filed 2025-05-12 | |||
| 2024-12-31 | 1.00 segment 10-K · filed 2025-03-20 | |||
| 2023-12-31 | 1.00 segment 10-K · filed 2024-03-29 | |||
| 2022-12-31 | 1.00 segment 10-K · filed 2023-03-29 | |||
| 2021-12-31 | 1.00 segment 10-K · filed 2022-03-02 | |||
| 2020-12-31 | 1.00 segment 10-K · filed 2021-03-08 | |||
| 2019-12-31 | 1.00 segment 10-K · filed 2020-03-11 | |||
| 2018-12-31 | 1.00 segment 10-K · filed 2019-03-18 | |||
| 2018-09-30 | 1.00 segment 10-Q · filed 2018-11-13 | |||
| 2018-06-30 | 1.00 segment 10-Q · filed 2018-08-09 | |||
| 2017-12-31 | 1.00 segment 10-Q · filed 2018-05-11 | |||
| 2017-09-30 | 1.00 segment 10-Q · filed 2017-11-07 | |||
| 2017-06-30 | 1.00 segment 10-Q · filed 2017-08-14 | |||
| 2017-03-31 | 1.00 segment 10-Q · filed 2017-05-09 | |||
| 2016-12-31 | 1.00 segment 10-K · filed 2017-03-14 | |||
| 2015-12-31 | 1.00 segment 10-K · filed 2016-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |